2-tert-Butyl-3-phenyl-chinoxalin | 15034-12-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-tert-Butyl-3-phenyl-chinoxalin
• 英文别名: 2-tert-Butyl-3-phenylquinoxaline
• CAS: 15034-12-5
• 化学式: C₁₈H₁₈N₂
• 分子量: 262.354
• InChiKey: AWMABZQTVZWNCD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-苯基-3,3-二甲基-1,2-丁二酮 在 溶剂黄146 、 邻苯二胺 作用下， 生成 2-tert-Butyl-3-phenyl-chinoxalin
  参考文献：
  名称：

  Acyloins from t-Butylglyoxal

  摘要：

  DOI：

  10.1021/ja01877a001

文献信息

• ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
  申请人：ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD.

  公开号：US20210175433A1

  公开（公告）日：2021-06-10

  The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound according to the present disclosure, it is possible to provide an organic electroluminescent device having improved driving voltage, luminous efficiency, lifetime and/or power efficiency properties.

  本公开涉及一种有机电致发光化合物和包括该化合物的有机电致发光器件。通过包含本公开的有机电致发光化合物，可以提供具有改进的驱动电压、发光效率、寿命和/或功率效率特性的有机电致发光器件。
• Heterocyclic compound and organic light-emitting element using same
  申请人：LG CHEM, LTD.

  公开号：US10032997B2

  公开（公告）日：2018-07-24

  The present specification provides a heterocyclic compound and an organic light emitting device using the same.

  本说明书提供了一种杂环化合物和使用该杂环化合物的有机发光器件。
• 4-AMINO-4-OXOBUTANOYL PEPTIDES AS INHIBITORS OF VIRAL REPLICATION
  申请人：Phadke Avinash

  公开号：US20100216725A1

  公开（公告）日：2010-08-26

  The invention provides 4-amino-4-oxobutanoyl peptides of Formula I and the pharmaceutically salts and hydrates thereof. The variables R, R 1 , R 6 -R 8 , R 16 , R 18 , R 19 , M, n, T, Y, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. The 4-amino-4-oxobutanoyl peptides disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptides and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain a 4-amino-4-oxobutanoyl peptides as the only active agent or may contain a combination of a 4-amino-4-oxobutanoyl peptides and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections.
• NEW 4-AMINO-4-OXOBUTANOYL PEPTIDES AS INHIBITORS OF VIRAL REPLICATION
  申请人：Phadke Avinash

  公开号：US20140113890A1

  公开（公告）日：2014-04-24

  The invention provides 4-amino-4-oxobutanoyl peptides of Formula I and the pharmaceutically salts and hydrates thereof. The variables R, R 1 , R 6 -R 8 , R 16 , R 18 , R 19 , M, n, T, Y, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. The 4-amino-4-oxobutanoyl peptides disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptides and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain a 4-amino-4-oxobutanoyl peptides as the only active agent or may contain a combination of a 4-amino-4-oxobutanoyl peptides and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections.
• HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME
  申请人：LG CHEM, LTD.

  公开号：US20160233431A1

  公开（公告）日：2016-08-11

  The present specification provides a heterocyclic compound and an organic light emitting device using the same.

表征谱图